Agios Pharmaceuticals
AGIO
#5006
Rank
NZ$3.38 B
Marketcap
NZ$56.68
Share price
-0.34%
Change (1 day)
-20.12%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -NZ$0.8 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are NZ$98.33 Million. In 2025 the company made an earning of -NZ$0.85 Billion a decrease over its 2024 earnings that were of -NZ$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.8 Billion-5.2%
2025 -NZ$0.85 Billion10.9%
2024 -NZ$0.76 Billion8.75%
2023 -NZ$0.7 Billion0.63%
2022 -NZ$0.7 Billion2.81%
2021 -NZ$0.68 Billion10.58%
2020 -NZ$0.61 Billion-18.41%
2019 -NZ$0.75 Billion15.72%
2018 -NZ$0.65 Billion12.99%
2017 -NZ$0.58 Billion59.61%
2016 -NZ$0.36 Billion69.32%
2015 -NZ$0.22 Billion119.28%
2014 -NZ$96.46 Million39.22%
2013 -NZ$69.29 Million69.1%
2012 -NZ$40.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.30 B-1,604.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.86 B-7,418.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.05 B-1,818.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-NZ$0.29 Billion-64.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.84 B-325.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B-132.48%๐Ÿ‡บ๐Ÿ‡ธ USA